Skip to main content
Log in

Saturated Fatty Acids Up-regulate COX-2 Expression in Prostate Epithelial Cells via Toll-like Receptor 4/NF-κB Signaling

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Cyclooxygenase-2 (COX-2) has been implicated in prostate carcinogenesis, and recently it has been confirmed to be a molecular target of saturated fatty acids (SFAs). In the present study, we investigated the effect of stearic acid (SA) and palmitic acid (PA), two of the most abundant SFAs contained in dietary fat, on COX-2 expression in prostate epithelial cells and the signaling transduction pathway involved. First, we demonstrated that both SA and PA increased the mRNA and protein expression of COX-2, and consistently induced the activation of NF-κB in RWPE-1, BPH-1 and PC-3 prostate epithelial cell lines. The effect of SA and PA on COX-2 over-expression and NF-κB activation was in a dose-dependent manner, and PA was more potent than SA at the same concentration. Then, we demonstrated inhibition of NF-κB using its specific inhibitor strikingly attenuated PA-induced COX-2 expression. Toll-like receptor 4 (TLR4) was revealed to be expressed on RWPE-1, BPH-1 and PC-3 cell lines by PCR and immunofluorescence staining, and blocking its signaling significantly inhibited PA induced COX-2 over-expression and NF-κB activation. Taken together, we demonstrated that SFAs can up-regulate COX-2 expression in prostate epithelial cells, and this effect was mediated mainly through the TLR4/NF-κB signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Siegel, R., D. Naishadham, and A. Jemal. 2013. Cancer statistics, 2013. CA: A Cancer Journal for Clinicians 63: 11–30.

    Google Scholar 

  2. Cullen, J., S. Elsamanoudi, S.A. Brassell, Y. Chen, M. Colombo, A. Srivastava, and D.G. McLeod. 2012. The burden of prostate cancer in Asian nations. Journal of Carcinogenesis 11: 7.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Zhang, J., I.B. Dhakal, Z. Zhao, and L. Li. 2012. Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: Role of nutrition transition. European Journal of Cancer Prevention 21: 480–489.

    Article  PubMed  Google Scholar 

  4. Cook, L.S., M. Goldoft, S.M. Schwartz, and N.S. Weiss. 1999. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. The Journal of Urology 161: 152–155.

    Article  CAS  PubMed  Google Scholar 

  5. Shimizu, H., R.K. Ross, L. Bernstein, R. Yatani, B.E. Henderson, and T.M. Mack. 1991. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. British Journal of Cancer 63: 963–966.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Corella, D., D.K. Arnett, K.L. Tucker, E.K. Kabagambe, M. Tsai, L.D. Parnell, C.Q. Lai, Y.C. Lee, D. Warodomwichit, P.N. Hopkins, and J.M. Ordovas. 2011. A high intake of saturated fatty acids strengthens the association between the fat mass and obesity-associated gene and BMI. The Journal of Nutrition 141: 2219–2225.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Ramon, J.M., R. Bou, S. Romea, M.E. Alkiza, M. Jacas, J. Ribes, and J. Oromi. 2000. Dietary fat intake and prostate cancer risk: A case–control study in Spain. Cancer Causes & Control 11: 679–685.

    Article  CAS  Google Scholar 

  8. Kurahashi, N., M. Inoue, M. Iwasaki, S. Sasazuki, and A.S. Tsugane. 2008. Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiology, Biomarkers & Prevention 17: 930–937.

    Article  CAS  Google Scholar 

  9. Lophatananon, A., J. Archer, D. Easton, R. Pocock, D. Dearnaley, M. Guy, Z. Kote-Jarai, L. O’Brien, R.A. Wilkinson, A.L. Hall, E. Sawyer, E. Page, J.F. Liu, S. Barratt, A.A. Rahman, R. Eeles, and K. Muir. 2010. Dietary fat and early-onset prostate cancer risk. The British Journal of Nutrition 103: 1375–1380.

    Article  CAS  PubMed  Google Scholar 

  10. Pelser, C., A.M. Mondul, A.R. Hollenbeck, and Y. Park. 2013. Dietary fat, fatty acids, and risk of prostate cancer in the NIH-AARP diet and health study. Cancer Epidemiology, Biomarkers & Prevention 22: 697–707.

    Article  CAS  Google Scholar 

  11. Kobayashi, N., R.J. Barnard, J. Said, J. Hong-Gonzalez, D.M. Corman, M. Ku, N.B. Doan, D. Gui, D. Elashoff, P. Cohen, and W.J. Aronson. 2008. Effect of low-fat diet on development of prostate cancer and Akt phosphorylation in the Hi-Myc transgenic mouse model. Cancer Research 68: 3066–3073.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Llaverias, G., C. Danilo, Y. Wang, A.K. Witkiewicz, K. Daumer, M.P. Lisanti, and P.G. Frank. 2010. A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer. The American Journal of Pathology 177: 3180–3191.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Huang, M., S. Narita, K. Numakura, H. Tsuruta, M. Saito, T. Inoue, Y. Horikawa, N. Tsuchiya, and T. Habuchi. 2012. A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling. Prostate 72: 1779–1788.

    Article  CAS  PubMed  Google Scholar 

  14. Bonorden, M.J., M.E. Grossmann, S.A. Ewing, O.P. Rogozina, A. Ray, and K.J. TRAMP prostate tumors in relationship to diet and obesity. Prostate Cancer 2012: 543970.

  15. Song, M.J., K.H. Kim, J.M. Yoon, and J.B. Kim. 2006. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochemical and Biophysical Research Communications 346: 739–745.

    Article  CAS  PubMed  Google Scholar 

  16. Lee, J.Y., K.H. Sohn, S.H. Rhee, and D. Hwang. 2001. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. The Journal of Biological Chemistry 276: 16683–16689.

    Article  CAS  PubMed  Google Scholar 

  17. Lee, J.Y., J. Ye, Z. Gao, H.S. Youn, W.H. Lee, L. Zhao, N. Sizemore, and D.H. Hwang. 2003. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. The Journal of Biological Chemistry 278: 37041–37051.

    Article  CAS  PubMed  Google Scholar 

  18. Wang, W., A. Bergh, and J.E. Damber. 2004. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium. Prostate 61: 60–72.

    Article  CAS  PubMed  Google Scholar 

  19. Wang, W., A. Bergh, and J.E. Damber. 2005. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clinical Cancer Research 11: 3250–3256.

    Article  CAS  PubMed  Google Scholar 

  20. Gupta, S., M. Srivastava, N. Ahmad, D.G. Bostwick, and H. Mukhtar. 2000. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate 42: 73–78.

    Article  CAS  PubMed  Google Scholar 

  21. Kirschenbaum, A., A.P. Klausner, R. Lee, P. Unger, S. Yao, X.H. Liu, and A.C. Levine. 2000. Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. Urology 56: 671–676.

    Article  CAS  PubMed  Google Scholar 

  22. Yoshimura, R., H. Sano, C. Masuda, M. Kawamura, Y. Tsubouchi, J. Chargui, N. Yoshimura, T. Hla, and S. Wada. 2000. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 89: 589–596.

    Article  CAS  PubMed  Google Scholar 

  23. Lee, L.M., C.C. Pan, C.J. Cheng, C.W. Chi, and T.Y. Liu. 2001. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia. Anticancer Research 21: 1291–1294.

    CAS  PubMed  Google Scholar 

  24. Uotila, P., E. Valve, P. Martikainen, M. Nevalainen, M. Nurmi, and P. Harkonen. 2001. Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer. Urological Research 29: 23–28.

    Article  CAS  PubMed  Google Scholar 

  25. Zhang, Q., J. Peng, X.H. Zhang, Y.L. Guo, and J. Jin. 2005. Study of effect and mechanism of cyclooxygenase-2 on the prostatic hyperplasia in rats. Chinese Journal of Urology 7: 468–471.

    Google Scholar 

  26. Zha, S., W.R. Gage, J. Sauvageot, E.A. Saria, M.J. Putzi, C.M. Ewing, D.A. Faith, W.G. Nelson, A.M. De Marzo, and W.B. Isaacs. 2001. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Cancer Research 61: 8617–8623.

    CAS  PubMed  Google Scholar 

  27. Khor, L.Y., K. Bae, A. Pollack, M.E. Hammond, D.J. Grignon, V.M. Venkatesan, S.A. Rosenthal, M.A. Ritter, H.M. Sandler, G.E. Hanks, W.U. Shipley, and A.P. Dicker. 2007. COX-2 expression predicts prostate-cancer outcome: Analysis of data from the RTOG 92–02 trial. The Lancet Oncology 8: 912–920.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Cohen, B.L., P. Gomez, Y. Omori, R.C. Duncan, F. Civantos, M.S. Soloway, V.B. Lokeshwar, and B.L. Lokeshwar. 2006. Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence. International Journal of Cancer 119: 1082–1087.

    Article  CAS  Google Scholar 

  29. Richardsen, E., R.D. Uglehus, J. Due, C. Busch, and L.T. Busund. 2010. COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-beta, IL-10 and Ki67. Cancer Epidemiology 34: 316–322.

    Article  CAS  PubMed  Google Scholar 

  30. Bin, W., W. He, Z. Feng, L. Xiangdong, C. Yong, K. Lele, Z. Hongbin, and G. Honglin. 2011. Prognostic relevance of cyclooxygenase-2 (COX-2) expression in Chinese patients with prostate cancer. Acta Histochemica 113: 131–136.

    Article  PubMed  Google Scholar 

  31. Kirschenbaum, A., X. Liu, S. Yao, and A.C. Levine. 2001. The role of cyclooxygenase-2 in prostate cancer. Urology 58: 127–131.

    Article  CAS  PubMed  Google Scholar 

  32. Dandekar, D.S., and B.L. Lokeshwar. 2004. Inhibition of cyclooxygenase (COX)-2 expression by Tet-inducible COX-2 antisense cDNA in hormone-refractory prostate cancer significantly slows tumor growth and improves efficacy of chemotherapeutic drugs. Clinical Cancer Research 10: 8037–8047.

    Article  CAS  PubMed  Google Scholar 

  33. Katkoori, V., K. Manne, V. Vital-Reyes, C. Rodriguez-Burford, C. Shanmugam, M. Sthanam, U. Manne, C. Chatla, S. Abdulkadir, and W. Grizzle. 2013. Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53. Biotechnic & Histochemistry 88: 38–46.

    Article  CAS  Google Scholar 

  34. Subbarayan, V., A.L. Sabichi, N. Llansa, S.M. Lippman, and D.G. Menter. 2001. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells. Cancer Research 61: 2720–2726.

    CAS  PubMed  Google Scholar 

  35. Glaser, C., H. Demmelmair, and B. Koletzko. 2010. High-throughput analysis of total plasma fatty acid composition with direct in situ transesterification. PLoS One 5: e12045.

    Article  PubMed Central  PubMed  Google Scholar 

  36. Pandalai, P.K., M.J. Pilat, K. Yamazaki, H. Naik, and K.J. Pienta. 1996. The effects of omega-3 and omega-6 fatty acids on in vitro prostate cancer growth. Anticancer Research 16: 815–820.

    CAS  PubMed  Google Scholar 

  37. Bassett, J.K., G. Severi, A.M. Hodge, R.J. Macinnis, R.A. Gibson, J.L. Hopper, D.R. English, and G.G. Giles. 2013. Plasma phospholipid fatty acids, dietary fatty acids and prostate cancer risk. International Journal of Cancer.

  38. Tsatsanis, C., A. Androulidaki, M. Venihaki, and A.N. Margioris. 2006. Signalling networks regulating cyclooxygenase-2. The International Journal of Biochemistry & Cell Biology 38: 1654–1661.

    Article  CAS  Google Scholar 

  39. Munford, R.S., and C.L. Hall. 1986. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234: 203–205.

    Article  CAS  PubMed  Google Scholar 

  40. Erridge, C., and N.J. Samani. 2009. Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arteriosclerosis, Thrombosis, and Vascular Biology 29: 1944–1949.

    Article  CAS  PubMed  Google Scholar 

  41. Shi, H., M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. The Journal of Clinical Investigation 116: 3015–3025.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Weatherill, A.R., J.Y. Lee, L. Zhao, D.G. Lemay, H.S. Youn, and D.H. Hwang. 2005. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. Journal of Immunology 174: 5390–5397.

    CAS  Google Scholar 

  43. Huang, S., J.M. Rutkowsky, R.G. Snodgrass, K.D. Ono-Moore, D.A. Schneider, J.W. Newman, S.H. Adams, and D.H. Hwang. 2012. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. Journal of Lipid Research 53: 2002–2013.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to Yi Ding and Tian-Jing Lv for their invaluable technical support. Funding for this study was provided by a grant from the National Nature Science Foundation of China (Grant number: 30973007).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jie Jin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, J., Hu, S., Cui, Y. et al. Saturated Fatty Acids Up-regulate COX-2 Expression in Prostate Epithelial Cells via Toll-like Receptor 4/NF-κB Signaling. Inflammation 37, 467–477 (2014). https://doi.org/10.1007/s10753-013-9760-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-013-9760-6

KEY WORDS

Navigation